(Q38318252)

2 September 2017

Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans (English)

1 reference

2 September 2017

1 reference

1 reference

7

Linhardt RJ

1 reference

2 September 2017

Toida T

1

1 reference

2 September 2017

Maruyama T

2

1 reference

2 September 2017

Ogita Y

3

1 reference

2 September 2017

Suzuki A

4

1 reference

2 September 2017

Toyoda H

5

1 reference

2 September 2017

Imanari T

6

1 reference

2 September 2017

1 December 1999

1 reference

International Journal of Biological Macromolecules

2 September 2017

1 reference

2 September 2017

26

1 reference

2 September 2017

4

1 reference

2 September 2017

233-241

1 reference

Cytodifferentiation and proteoglycan biosynthesis

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Structure and function of heparan sulphate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Structure and biological activity of heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Hyaluronan: its nature, distribution, functions and turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Angiogenesis induced by degradation products of hyaluronic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Chemical and Pharmacological Studies on N-Resulfated Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Infrared spectroscopy of heparins suggests that the region 750-950 cm-1 is sensitive to changes in iduronate residue ring conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Infra-red spectroscopic studies of some polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

Dermatan sulfate as a potential therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0141-8130%2899%2900088-4

7 January 2021

10.1016/S0141-8130(99)00088-4

Identifiers

DOI

1 reference

2 September 2017

1 reference